Definium Therapeutics, Inc. (DFTX)
16.77
+1.72
(+11.43%)
USD |
NASDAQ |
Jan 20, 16:00
16.76
-0.01
(-0.06%)
After-Hours: 16:34
Definium Therapeutics EPS Diluted (Quarterly): -0.7832 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.26M |
| Total Expenses (Quarterly) | 67.26M |
| Enterprise Value | 1.314B |
| Earnings Yield | -11.76% |
| Normalized Earnings Yield | -10.66 |